An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of Sinusitis

NCT01920893 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Nasal Polyps

Interventions

DRUG: Placebo (for dupilumab)
DRUG: Dupilumab
DRUG: Mometasone furoate nasal spray

Sponsor

Sanofi

Collaborators

[object Object]